Genesys International Corporation Share Price

Genesys Intl.

CMP as on 23-Oct-20 15:02

₹ 50.40
2.40 5%

Open

₹ 47.00

Turnover (lac)

₹ 3

Prev. Close

₹ 48.00

Day's Vol (shares)

₹ 5,311

Day's Range (₹)

₹ 47.00
₹ 50.40

CMP as on23-Oct-20 11:36

₹ 49.35
2.35 5%

Open

₹ 49.35

Turnover (lac)

Prev. Close

₹ 47.00

Day's Vol (shares)

₹ 25

Day's Range

₹ 49.35
₹ 49.35

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 01-Sep-2020 - -
the Board of Directors of the Company, at their meeting held today has inter alia considered and Page 24 bu010920.txt approved: i. The Board approved to convene 38th Annual General Meeting on Monday, September 28, 2020 at 4.00 p.m. through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) ii. The Register of Members and Share Transfer Book of the Company will remain closed from September 22, 2020 to September 28, 2020 for the purpose of Annual General Meeting. iii. the cut-off date viz. September 21, 2020 may cast their vote electronically. The remote e-voting period will commence at 9.00 a.m. on Friday, September 25, 2020 and will end at 5.00 p.m. on Sunday, September 27, 2020. iv. The Board approved the Re-appointment of Mr. Manish Patel as Independent Director for a second term v. The Board approved new Genesys ESOP Scheme- 2020 subject to approval of shareholders in the forthcoming AGM The meeting of Board commenced at 4:00 p.m. and concluded at 4:45 p.m.
Board Meeting - 24-Jul-2020 - -
GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Friday, July 31, 2020, to inter alia, consider and approve the unaudited (standalone and consolidated) financial results of the Company for the quarter ended June 30, 2020. In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today on July 31, 2020 has inter alia 1. Approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2020. Copies of the following are enclosed: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2020; ii. Limited Review Report of the Statutory Auditors on aforesaid results. 2. The Board decided to introduce new ESOP Scheme 2020 subject to approval of shareholders of Company in forthcoming Annual General Meeting. The meeting of Board commenced at 4:45 p.m. and concluded at 5.20 p.m. You are requested to take the above on your records. In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today on July 31, 2020 has inter alia 1. Approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2020. Copies of the following are enclosed: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2020; ii. Limited Review Report of the Statutory Auditors on aforesaid results. 2. The Board decided to introduce new ESOP Scheme 2020 subject to approval of shareholders of Company in forthcoming Annual General Meeting. The meeting of Board commenced at 4:45 p.m. and concluded at 5.20 p.m. You are requested to take the above on your records. Thanking You, Yours faithfully, For Genesys International Corporation Limited Vineet Chopra Vice President - Legal & Company Secretary Encl.: As above (As Per BSE Announcement dated on 31.07.2020)
Board Meeting - 23-Jun-2020 - -
GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2020 ,inter alia, to consider and approve 1. Consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2020. 2. Consider recommendation of dividend on equity shares, if any, for the financial year ended March 31, 2020. Further to our earlier intimation on 23rd June 2020 for Board meeting scheduled to be held on 29th June, 2020 at Registered Office, we would like to inform you that due to current Pandemic situation, in case there are administrative restrictions / difficulties in holding the meeting at registered office the venue of Board meeting may be changed suitably to any other place. Please take the above on your records. (As Per BSE Announcement Dated on 24.06.2020) In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today has inter alia considered and approved:- i. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2020 along with Statement of Asset and Liabilities as at March 31, 2020. Copies of the following enclosed as Annexure A a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2020 b. Auditors Report along-with a Declaration in respect of Unmodified opinion on the Audited Financial Results ii. The Board of Directors has not recommended any Dividend on Equity Shares for the Financial Year 2019-2020. The meeting of Board commenced at 5:20 p.m. and concluded at 7:10 p.m. You are requested to take the above on your records. (As Per BSE Announcement Dated on 29/06/2020)
Board Meeting - 03-Feb-2020 - -
GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held at Registered Office on Tuesday, February 11, 2020, inter alia, to Consider and approve the un-audited (standalone and consolidated) financial results of the Company for the third quarter ended December 31, 2019. Please take the above on your records. In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today, February 11, 2020 has inter alia approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2019. Copies of the following are enclosed: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2019. ii. Limited Review Report of the Statutory Auditors on aforesaid results. The meeting of the Board commenced at 06.00 p.m. and concluded at 06:30 p.m. You are requested to take the above on your records. In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today, February 11, 2020 has inter alia approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2019. Copies of the following are enclosed: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2019. ii. Limited Review Report of the Statutory Auditors on aforesaid results. The meeting of the Board commenced at 06.00 p.m. and concluded at 06:30 p.m. You are requested to take the above on your records (As Per BSE Announcement Dated 11.02.2020)
Board Meeting - 24-Dec-2019 - -
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today, December 24, 2019 has inter alia approved:- i. Mr. Manish Chhaganlal Patel (DIN No. 03051315) has been appointed as an Additional Director - Non - executive Independent Director for the period of one year w.e.f December 24, 2019 subject to approval of the Shareholders of the Company at the next Annual General Meeting. He is not related to any of the Director/Key Managerial Personnel of the Company. ii. Resignation of Mr. Sohel Malik as an Executive Director of the Company w.e.f. closure of business hours of December 24, 2019. The meeting of the Board commenced at 04.30 pm and concluded at 05:00 pm. You are requested to take the above on your records.
Board Meeting - 07-Nov-2019 - -
GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve the un-audited (standalone and consolidated) financial results of the Company for the second quarter ended September 30, 2019. In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today, November 14, 2019 has inter alia approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2019. Copies of the following are enclosed: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2019. ii. Limited Review Report of the Statutory Auditors on aforesaid results. (As Per BSE Announcement Dated on 14/11/2019)